A community for students.

Here's the question you clicked on:

55 members online
  • 0 replying
  • 0 viewing

anonymous

  • 5 years ago

I'm curently valuing Sanitas and in last 3 years and in projections it's Reinvestment rate is negative as a result of negative difference between capex and D&A.I want to make valuation from fundamental growth, rather than management estimates.What can I do with negative Re.Rate?Thanks in advance.

  • This Question is Closed
  1. anonymous
    • 5 years ago
    Best Response
    You've already chosen the best response.
    Medals 0

    If you assume that it will continue into the future, your cash flows will exceed your earnings (which is not unusual) but your growth rates should reflect this as well

  2. anonymous
    • 5 years ago
    Best Response
    You've already chosen the best response.
    Medals 0

    Aswath,you think it's better to use the FCFF projections by management estimates.They have made valuation,but there are some mistakes, such as double counting of cash.During the last 3 years Sanitas' Finance income was growing, but in projections it's 0.

  3. anonymous
    • 5 years ago
    Best Response
    You've already chosen the best response.
    Medals 0

    The problem with management forecasts is that they are biased. I, personally, would never take management forecasts at face value.

  4. Not the answer you are looking for?
    Search for more explanations.

    • Attachments:

Ask your own question

Sign Up
Find more explanations on OpenStudy
Privacy Policy

Your question is ready. Sign up for free to start getting answers.

spraguer (Moderator)
5 → View Detailed Profile

is replying to Can someone tell me what button the professor is hitting...

23

  • Teamwork 19 Teammate
  • Problem Solving 19 Hero
  • You have blocked this person.
  • ✔ You're a fan Checking fan status...

Thanks for being so helpful in mathematics. If you are getting quality help, make sure you spread the word about OpenStudy.

This is the testimonial you wrote.
You haven't written a testimonial for Owlfred.